Successful Treatment of Electrographic Status Epilepticus of Sleep With Felbamate in a Patient With SLC9A6 Mutation

详细信息    查看全文

• 作者：Rohini Coorg ; MD^a ; ^b ; ^c ; ¹ ; ^{coorg@bcm.edu" class="auth_mail" title="E-mail the corresponding author} ; Judith L.Z. Weisenberg ; MD^a ; ^{weisenbergj@neuro.wustl.edu" class="auth_mail" title="E-mail the corresponding author}
• 关键词：epilepsy ; SLC9A6 ; ESES ; felbamate ; Christianson syndrome
• 刊名：Pediatric Neurology
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：53
• 期：6
• 页码：527-531
• 全文大小：1408 K

文摘

Mutations of SLC9A6 may cause an X-linked clinical syndrome first described by Christianson in 1999 in which affected males exhibited profound intellectual disability, autism, drug-resistant epilepsy, ophthalmoplegia, mild craniofacial dysmorphism, microcephaly, and ataxia.

Methods

We describe a child with an SLC9A6 mutation and an electroencephalographic pattern consistent with electrographic status epilepticus of sleep.

Results

Our patient's electrographic status epilepticus of sleep resolved after treatment with felbamate. Following treatment, he remained seizure-free but did not make significant or lasting gains in language.

Conclusion

Our report extends the clinical epilepsy phenotype in children with SLC9A6 mutations to include electrographic status epilepticus of sleep. In addition, felbamate was an effective treatment for electrographic status epilepticus of sleep in our patient.